Journal: Journal of managed care & specialty pharmacy
This publication summarizes a virtual expert panel discussion convened by AMCP Market Insights in February 2025, focusing on the management of estrogen receptor-positive (ER+)/HER2-negative metastatic breast cancer (mBC).
The panel addressed key challenges, including:
- Navigating the evolving treatment landscape
- Emphasizing the patient care journey
- Maintaining quality care
- Managing payer impact
- Evaluating new therapies
The discussion also generated suggested best practices for payers to optimize care and resource allocation for patients with ER+/HER2- mBC.